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rtificial Intelligence (AI) is 
increasingly being applied in 
healthcare and medicine, with the 
greatest impact being achieved thus far in 
medical imaging. These are technologies 
that are capable of performing a task that 
usually requires human perception and 
judgement, which can make them 
controversial in a healthcare setting. In this 
article we will explore some of the 
opportunities and risks in using AI in 
healthcare, as well as policy 
recommendations for improving their use 
and acceptance. 
 
Opportunities 
New AI technologies can identify subtle 
signs of disease in medical images faster 
and more accurately than humans. One 
example is the deep learning algorithm 
developed by Enlitic, Picture Archiving and 
Communications (PAC), which detects signs 
of disease in medical imaging modalities 
including MRI, CT scans, ultrasound and x-
rays. PAC contextualizes the imaging data 
by comparing it to large datasets of past 
images, and by analysing ancillary clinical 
data, including clinical reports and 
laboratory studies. As a result, Enlitic claims 
doctors may be able to achieve 50-70% 
more accurate results with PAC compared to 
human radiologists working alone, and at 
50,000 times faster speed. 
 
Another key area of medicine where AI is 
impacting is in clinical decision-making, in 
particular disease diagnosis. These AI 
technologies can ingest, analyse and report 
on large volumes of data, across different 
modalities, to detect disease and guide 
clinical decisions. For example, Lumiata’s 
graph-based analytics and risk prediction 
system has reportedly “ingested more than 
160 million data points from textbooks, 
journal articles, public data sets and other 
places in order to build graph 
representations of how illnesses and 
patients are connected.”
2
 This new 
knowledge can help in understanding the 
multifactorial basis of disease and guide the 
development of new treatments.  
 
Big data also has a role to play. 
Complementary technologies such as ‘smart 
wearables’ have the potential to increase the 
power of medical AI through the provision of 
large volumes of diverse health-relevant 
data, collected directly from the user. The 
combined impact of these technologies will 
help us to move closer towards achieving 
‘precision medicine’, an emerging approach 
to disease treatment and prevention that 
takes into account individual variability in 
genes, environment, and lifestyle. 
The combined impact of these 
technologies will help us to move 
closer towards achieving ‘precision 
medicine,’ an emerging approach to 
disease treatment and prevention. 
Hospitals, doctors and nurses are 
overworked and cost and time efficiencies 
are always being sought. Automating 
elements of medical practice means 
A 
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clinicians will increasingly have more time 
to spend with the patient on those tasks 
where human-delivered care is key. Focus 
will transition to working on more complex 
cases, clinical interpretation, and patient 
communication. These areas can also 
benefit from AI input, and together should 
help the medical and technology community 
to address a greater number of medical 
needs and overall improve the delivery of 
healthcare.  
 
Risks 
While we can look forward to the benefits of 
AI to improve healthcare, the adoption of 
these technologies is not without 
considerable potential risks. The clinical 
setting, healthcare provision and patient 
data necessitate the highest level of 
accuracy, reliability, security and privacy.  
 
Consistent accuracy is important to 
preserve trust in the technology, but AI is 
still in its infancy. Whilst AI systems may 
have been trained on comprehensive 
datasets, in the clinical setting they may 
encounter data and scenarios that they have 
not been trained on, potentially making them 
less accurate and reliable and therefore 
putting at risk patient safety. As 
aforementioned, medical AI systems may 
work with consumer-facing smart 
wearables, and use the data they generate. 
A recent study showed that the heart rate 
readings provided by one of the most 
popular smart wearables, the Fitbit 
PurePulse Trackers, “do not provide a valid 
measure of the users’ heart rate and cannot 
be used to provide a meaningful estimate of 
a user’s heart rate”, and in fact differed 
from ECG readings by an average of 20 
bpm.
5
  
 
The data collected by these devices is also 
sensitive and needs to be safeguarded with 
the highest security standards. A study
6
 
showed that 20 out of the 43 fitness apps 
analysed included high-risk data, such as 
address, financial information, full name, 
health information, location and date of 
birth. If we work from the premise that all 
personal data can be identifiable, then it is 
critical that all data used in a medical setting 
is safeguarded. Given that there is an 
important distinction between clinical and 
non-clinical use, and the fact that data from 
non-clinical smart wearables may feed into 
clinical AI systems, it will be necessary to 
identify where clinical-level accuracy and 
reliability needs to be implemented.  
 
Both accuracy and security are required to 
foster trust in these new technologies. A 
lack of trust in AI systems may significantly 
impinge adoption of technologies that may 
otherwise offer significant improvements in 
patient outcomes. Trust can be gained 
through greater transparency in how results 
are achieved. For instance, how the AI 
system came to a recommendation that the 
patient should have a mastectomy. Currently 
this is a technological issue that the 
technical community is addressing, and so 
solutions should come henceforth. 
 
Addressing the risks posed by medical AI is 
important as technological development and 
implementation ramp up growth. Industry 
estimates predict that by 2018, 50 percent 
of the more than 3.4 billion smartphone and 
tablet users will have downloaded mobile 
health apps
7
. 
 
Encouraging the Rapid, Ethical, 
and Responsible Growth of 
Medical AI 
The accuracy, reliability, security and 
clinical use of medical AI technologies would 
need to be ensured through a combination of 
standards and regulation. Existing 
regulatory frameworks would need to 
develop to address medical AI technologies, 
which have their own ethical problems to 
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contend with. Artificial intelligence 
programs may be able to learn and alter 
their recommendations in ways not intended 
or foreseen by their creators. That, and the 
diversity of development approaches across 
the planet,
8
 poses challenges for current 
regulatory frameworks that would therefore 
need to evolve to define guidelines and best 
practice. 
 
The development of standards for data 
collection and testing of medical AI 
technologies should be a community-driven 
effort, led by clinicians, industry, academia 
and stakeholders. Dedicated research and 
open-source development addressing the 
key issues would facilitate the growth of 
medical AI. A comparable undertaking can 
be found in the related field of genomic 
medicine. The Global Alliance for Genomics 
and Health brings together over 375 leading 
institutions working in healthcare, research, 
disease advocacy, life science, and 
information technology, to provide 
recommendations and solutions to mitigate 
the risks associated with the accumulation 
of large datasets of medical and genetic 
information.  
As the role of the clinician will evolve, 
medical education will need to focus 
more on complex disease scenarios, 
and developing skillsets to navigate, 
understand, and communicate the 
myriad of data that may be called upon 
for a given medical scenario. 
This is very feasible. A ‘Global Alliance for 
Artificial Intelligence in Health’ could 
collaborate with the planned NHS ‘test bed’ 
sites, real world sites for ‘combinatorial’ 
innovations that integrate new technologies, 
new staffing models and payment-for-
outcomes
9
. The NHS ‘test beds’, which are 
planned over the next 5 years, would 
facilitate the implementation of AI 
technologies within clinical settings. 
Furthermore, putting in place a mechanism 
to inform the relevant national and 
international public bodies about the results 
and outcomes is also important. 
 
Medical education would also need to 
expand to better include new technology. 
Today’s educational curriculum 
encompasses minimal teaching of 
technologies that medical practitioners will 
use, or come into contact with in their 
profession. For AI systems to be fully 
appreciated and implemented as they are 
intended within clinical practice, there would 
need to be dedicated training in 
understanding and working with these new 
technologies, which will even take on 
certain clinical tasks with complete 
autonomy, such as diagnosis and surgery. 
Furthermore, as the role of the clinician will 
evolve, medical education will need to focus 
more on complex disease scenarios, and 
developing skillsets to navigate, understand 
and communicate the myriad of data that 
may be called upon for a given medical 
scenario. In order to equip medical students 
to meet these demands, medical education 
will need to be more holistic to incorporate 
understanding of the technologies and the 
results they generate. 
   
Finally, healthcare IT systems today can be 
fragmented and cumbersome to work with, 
presenting challenges for implementation of 
new technologies. Interoperability and IT 
procurement would need to evolve to meet 
the growing need for advanced technologies 
in clinical practice, and would need to 
ensure that the data and outcomes are 
integrated seamlessly into an end-to-end 
care pathway. 
 
Conclusion 
If policymakers, hospitals and universities 
consider these policy issues, we would be in 
a better place to take advantages of AI’s 
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opportunities for healthcare. Without them, 
the risks of poor accuracy, security and 
understanding may cause untold problems. 
With such a controversial technology such 
as artificial intelligence, it is imperative that 
policymakers make decisions while the 
technology is still young, before they are 
forced to make policy reactively. 
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